Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d)
of
The Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported) June
4, 2007
(Exact
name of registrant as specified in its charter)
|
Delaware
|
001-32616
|
98-0381367
|
|
(State
or other Jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
Room
2001, FanMei Building
No.
1
Naguan Zhengjie
X’ian,
Shaanxi 710068
People’s
Republic of China
(Address
of Principal Executive Offices)
(Registrant’s
Telephone Number, Including Area Code)
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
(b)
On
June
4, 2007, Yiliang Lai resigned as Chief Financial Officer of Bodisen Biotech,
Inc. (the “Company”).
(c)
On
June
4, 2007, the Board of Directors appointed Junyan Tong, age 36, to serve as
the
Company’s Chief Financial Officer, effective immediately.
Ms.
Tong
has served as the Company’s Assistant Chief Financial Officer since 2005. From
1998-2002, Ms. Tong was Chief Financial Officer of Shenzhen Rongxun Industry
Co., Ltd, a fitness equipment manufacturing company, where she was in charge
of
banking, tax matters, foreign currency issues, general ledgers, budgeting and
financial analysis. From 1995-1998, Ms. Tong served as Financial Manager of
Guangdong Zhongyunhui Electric Co., Ltd., a telecommunications company. There,
Ms. Tong was responsible for cost control, budgeting and foreign currency
issues. From 1991-1995, Ms. Tong was Accounting Manager at Guangdong Dongguan
Anbao Industry Co., Ltd., a China-based electronics appliance company. As
Accounting Manager, Ms. Tong handled financial statements, general ledger and
cost control matters. Ms. Tong holds a degree in financial management from
Harbin Economic Management Institute.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
| |
|
BODISEN
BIOTECH, INC.
(Registrant)
|
| |
|
|
| |
|
| Date:
June
8, 2007 |
|
/s/ Bo
Chen |
| |
Bo
Chen
Chairman,
Chief Executive Officer and President
|